Norvipren

Primær information

  • Handelsnavn:
  • Norvipren 200 mikrogram resoribletter, sublinguale
  • Dosering:
  • 200 mikrogram
  • Lægemiddelform:
  • resoribletter, sublinguale
  • Brugt til:
  • Mennesker
  • Medicin typen:
  • Allopatiske stof

Dokumenter

  • for den brede offentlighed:
  • Oplysningerne indlægssedlen for dette produkt er i øjeblikket ikke tilgængelig, kan du sende en anmodning til vores kundeservice, og vi vil give dig besked, så snart vi er i stand til at opnå det.


    Anmode informationsbrochure for offentligheden.

  • for sundhedspersonale:
  • Oplysningerne indlægssedlen for dette produkt er i øjeblikket ikke tilgængelig, kan du sende en anmodning til vores kundeservice, og vi vil give dig besked, så snart vi er i stand til at opnå det.


    Anmode informationsbrochure for sundhedspersonale.

Lokation

  • Fås i:
  • Norvipren 200 mikrogram resoribletter, sublinguale
    Danmark
  • Sprog:
  • dansk

Andre oplysninger

Status

  • Kilde:
  • Lægemiddelstyrelsen - Danish Medicines Agency
  • Autorisationsnummer:
  • 56169
  • Sidste ændring:
  • 22-02-2018
  • Oplysningerne indlægssedlen for dette produkt er i øjeblikket ikke tilgængelig, kan du sende en anmodning til vores kundeservice, og vi vil give dig besked, så snart vi er i stand til at opnå det.

    Anmode informationsbrochure for offentligheden.

1-12-2017

Statement from FDA Commissioner Scott Gottlieb, M.D., on the approval of a new formulation of buprenorphine and FDA’s efforts to promote more widespread innovation and access to opioid addiction treatments

Statement from FDA Commissioner Scott Gottlieb, M.D., on the approval of a new formulation of buprenorphine and FDA’s efforts to promote more widespread innovation and access to opioid addiction treatments

Statement from FDA Commissioner Scott Gottlieb, M.D., on the approval of a new formulation of buprenorphine and FDA’s efforts to promote more widespread innovation and access to opioid addiction treatments

FDA - U.S. Food and Drug Administration

1-12-2017

FDA approves first once-monthly buprenorphine injection, a medication-assisted treatment option for opioid use disorder

FDA approves first once-monthly buprenorphine injection, a medication-assisted treatment option for opioid use disorder

FDA approves first once-monthly buprenorphine injection, a medication-assisted treatment option for opioid use disorder

FDA - U.S. Food and Drug Administration

20-9-2017

FDA Drug Safety Communication: FDA urges caution about withholding opioid addiction medications from patients taking benzodiazepines or CNS depressants: careful medication management can reduce risks

FDA Drug Safety Communication: FDA urges caution about withholding opioid addiction medications from patients taking benzodiazepines or CNS depressants: careful medication management can reduce risks

Based on our additional review, the U.S. Food and Drug Administration (FDA) is advising that the opioid addiction medications buprenorphine and methadone should not be withheld from patients taking benzodiazepines or other drugs that depress the central nervous system (CNS). The combined use of these drugs increases the risk of serious side effects; however, the harm caused by untreated opioid addiction usually outweighs these risks. Careful medication management by health care professionals can reduce...

FDA - U.S. Food and Drug Administration

20-9-2017

Opioid Addiction Medications in Patients Taking Benzodiazepines or CNS Depressants: Drug Safety Communication - Careful Medication Management Can Reduce Risks

Opioid Addiction Medications in Patients Taking Benzodiazepines or CNS Depressants: Drug Safety Communication - Careful Medication Management Can Reduce Risks

Health care professionals should develop a treatment plan when buprenorphine or methadone is used in combination with benzodiazepines or other CNS depressants.

FDA - U.S. Food and Drug Administration

3-4-2018

BUPRENORPHINE AND NALOXONE Tablet [Actavis Pharma, Inc.]

BUPRENORPHINE AND NALOXONE Tablet [Actavis Pharma, Inc.]

Updated Date: Apr 3, 2018 EST

US - DailyMed

26-2-2018

SUBLOCADE (Buprenorphine) Solution [Indivior Inc.]

SUBLOCADE (Buprenorphine) Solution [Indivior Inc.]

Updated Date: Feb 26, 2018 EST

US - DailyMed

14-2-2018

SIMBADOL (Buprenorphine) Injection [Zoetis Inc.]

SIMBADOL (Buprenorphine) Injection [Zoetis Inc.]

Updated Date: Feb 14, 2018 EST

US - DailyMed

13-2-2018

BUPRENORPHINE HCL AND NALOXONE HCL (Buprenorphine And Naloxone) Tablet [AvPAK]

BUPRENORPHINE HCL AND NALOXONE HCL (Buprenorphine And Naloxone) Tablet [AvPAK]

Updated Date: Feb 13, 2018 EST

US - DailyMed

6-2-2018

BUTRANS (Buprenorphine) Patch, Extended Release [Purdue Pharma LP]

BUTRANS (Buprenorphine) Patch, Extended Release [Purdue Pharma LP]

Updated Date: Feb 6, 2018 EST

US - DailyMed

2-2-2018

BUPRENORPHINE HCL Tablet [West-Ward Pharmaceuticals Corp.]

BUPRENORPHINE HCL Tablet [West-Ward Pharmaceuticals Corp.]

Updated Date: Feb 2, 2018 EST

US - DailyMed

19-1-2018

BUPRENORPHINE Patch [Lake Erie Medical DBA Quality Care Products LLC]

BUPRENORPHINE Patch [Lake Erie Medical DBA Quality Care Products LLC]

Updated Date: Jan 19, 2018 EST

US - DailyMed

19-1-2018

BUPRENORPHINE HYDROCHLORIDE Tablet [REMEDYREPACK INC.]

BUPRENORPHINE HYDROCHLORIDE Tablet [REMEDYREPACK INC.]

Updated Date: Jan 19, 2018 EST

US - DailyMed

19-1-2018

BUPRENORPHINE AND NALOXONE Tablet [Sun Pharmaceutical Industries Limited ]

BUPRENORPHINE AND NALOXONE Tablet [Sun Pharmaceutical Industries Limited ]

Updated Date: Jan 19, 2018 EST

US - DailyMed

8-1-2018

BUPRENORPHINE HYDROCHLORIDE Injection, Solution [American Regent, Inc.]

BUPRENORPHINE HYDROCHLORIDE Injection, Solution [American Regent, Inc.]

Updated Date: Jan 8, 2018 EST

US - DailyMed

2-1-2018

BUPRENORPHINE Tablet [Bryant Ranch Prepack]

BUPRENORPHINE Tablet [Bryant Ranch Prepack]

Updated Date: Jan 2, 2018 EST

US - DailyMed

22-12-2017

BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE DIHYDRATE Tablet [SpecGx LLC]

BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE DIHYDRATE Tablet [SpecGx LLC]

Updated Date: Dec 22, 2017 EST

US - DailyMed

21-12-2017

BUPRENORPHINE HYDROCHLORIDE Tablet [A-S Medication Solutions]

BUPRENORPHINE HYDROCHLORIDE Tablet [A-S Medication Solutions]

Updated Date: Dec 21, 2017 EST

US - DailyMed

20-12-2017

BUPRENORPHINE HYDROCHLORIDE Tablet [Hi-Tech Pharmacal Co., Inc.]

BUPRENORPHINE HYDROCHLORIDE Tablet [Hi-Tech Pharmacal Co., Inc.]

Updated Date: Dec 20, 2017 EST

US - DailyMed

18-12-2017

BUPRENORPHINE Patch, Extended Release [Lake Erie Medical DBA Quality Care Products LLC]

BUPRENORPHINE Patch, Extended Release [Lake Erie Medical DBA Quality Care Products LLC]

Updated Date: Dec 18, 2017 EST

US - DailyMed

15-12-2017

BELBUCA (Buprenorphine Hydrochloride) Film [Endo Pharmaceuticals, Inc.]

BELBUCA (Buprenorphine Hydrochloride) Film [Endo Pharmaceuticals, Inc.]

Updated Date: Dec 15, 2017 EST

US - DailyMed

21-11-2017

BUPRENORPHINE Tablet [Actavis Pharma, Inc.]

BUPRENORPHINE Tablet [Actavis Pharma, Inc.]

Updated Date: Nov 21, 2017 EST

US - DailyMed

14-11-2017

Zubsolv (Mundipharma Corporation Limited)

Zubsolv (Mundipharma Corporation Limited)

Zubsolv (Active substance: buprenorphine / naloxone) - Centralised - Authorisation - Commission Decision (2017)7640 of Tue, 14 Nov 2017 European Medicines Agency (EMA) procedure number: EMEA/H/C/4407

Europe -DG Health and Food Safety

24-10-2017

PROBUPHINE (Buprenorphine Hydrochloride) Implant [Braeburn Pharmaceuticals]

PROBUPHINE (Buprenorphine Hydrochloride) Implant [Braeburn Pharmaceuticals]

Updated Date: Oct 24, 2017 EST

US - DailyMed

24-10-2017

BUPRENORPHINE AND NALOXONE Tablet [Lannett Company, Inc..]

BUPRENORPHINE AND NALOXONE Tablet [Lannett Company, Inc..]

Updated Date: Oct 24, 2017 EST

US - DailyMed

23-10-2017

BUPRENORPHINE HYDROCHLORIDE Tablet [PD-Rx Pharmaceuticals, Inc.]

BUPRENORPHINE HYDROCHLORIDE Tablet [PD-Rx Pharmaceuticals, Inc.]

Updated Date: Oct 23, 2017 EST

US - DailyMed

18-10-2017

BUPRENORPHINE AND NALOXONE Tablet [Teva Pharmaceuticals USA, Inc.]

BUPRENORPHINE AND NALOXONE Tablet [Teva Pharmaceuticals USA, Inc.]

Updated Date: Oct 18, 2017 EST

US - DailyMed

10-10-2017

BUPRENORPHINE Tablet [Sun Pharmaceutical Industries Limited ]

BUPRENORPHINE Tablet [Sun Pharmaceutical Industries Limited ]

Updated Date: Oct 10, 2017 EST

US - DailyMed

4-10-2017

BUPRENORPHINE (Buprenorphine Hydrochloride) Tablet [REMEDYREPACK INC.]

BUPRENORPHINE (Buprenorphine Hydrochloride) Tablet [REMEDYREPACK INC.]

Updated Date: Oct 4, 2017 EST

US - DailyMed

15-9-2017

BUPRENORPHINE Tablet [Contract Pharmacy Services-PA]

BUPRENORPHINE Tablet [Contract Pharmacy Services-PA]

Updated Date: Sep 15, 2017 EST

US - DailyMed

15-9-2017

BUPRENORPHINE HYDROCHLORIDE Tablet [Contract Pharmacy Services-PA]

BUPRENORPHINE HYDROCHLORIDE Tablet [Contract Pharmacy Services-PA]

Updated Date: Sep 15, 2017 EST

US - DailyMed

15-9-2017

BUPRENORPHINE HYDROCHLORIDE SUBLINGUAL Tablet [Contract Pharmacy Services-PA]

BUPRENORPHINE HYDROCHLORIDE SUBLINGUAL Tablet [Contract Pharmacy Services-PA]

Updated Date: Sep 15, 2017 EST

US - DailyMed

15-9-2017

BUPRENORPHINE HCL Tablet [Contract Pharmacy Services-PA]

BUPRENORPHINE HCL Tablet [Contract Pharmacy Services-PA]

Updated Date: Sep 15, 2017 EST

US - DailyMed

14-9-2017

Withdrawn application:  Somnena, buprenorphine, Initial authorisation

Withdrawn application: Somnena, buprenorphine, Initial authorisation

Europe - EMA - European Medicines Agency

14-9-2017

BUPRENORPHINE (Buprenorphine Hydrochloride) Tablet [Contract Pharmacy Services-PA]

BUPRENORPHINE (Buprenorphine Hydrochloride) Tablet [Contract Pharmacy Services-PA]

Updated Date: Sep 14, 2017 EST

US - DailyMed

25-8-2017

BUPRENORPHINE (Buprenorphine) Tablet [REMEDYREPACK INC.]

BUPRENORPHINE (Buprenorphine) Tablet [REMEDYREPACK INC.]

Updated Date: Aug 25, 2017 EST

US - DailyMed

1-8-2017

BUPRENORPHINE HYDROCHLORIDE SUBLINGUAL Tablet [REMEDYREPACK INC.]

BUPRENORPHINE HYDROCHLORIDE SUBLINGUAL Tablet [REMEDYREPACK INC.]

Updated Date: Aug 1, 2017 EST

US - DailyMed

14-7-2017

BUPRENORPHINE HYDROCHLORIDE SUBLINGUAL Tablet [Mylan Pharmaceuticals Inc.]

BUPRENORPHINE HYDROCHLORIDE SUBLINGUAL Tablet [Mylan Pharmaceuticals Inc.]

Updated Date: Jul 14, 2017 EST

US - DailyMed

3-7-2017

BUPRENORPHINE Patch [Rhodes Pharmaceuticals L.P.]

BUPRENORPHINE Patch [Rhodes Pharmaceuticals L.P.]

Updated Date: Jul 3, 2017 EST

US - DailyMed

30-5-2017

BUPRENORPHINE Patch, Extended Release [Teva Pharmaceuticals USA, Inc.]

BUPRENORPHINE Patch, Extended Release [Teva Pharmaceuticals USA, Inc.]

Updated Date: May 30, 2017 EST

US - DailyMed

23-5-2017

BUPRENORPHINE HYDROCHLORIDE Tablet [Bryant Ranch Prepack]

BUPRENORPHINE HYDROCHLORIDE Tablet [Bryant Ranch Prepack]

Updated Date: May 23, 2017 EST

US - DailyMed